glutathione mutations in sclc patients Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming EGFR-Mutant Lung Cancer Frontiers | Targeting lung cancer:
Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Oxidative Stress and its Role in Carcinogenesis Cell Biochemistry and Biophysics Springer Nature Link Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Nature Communications
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



